Expanded analyses of NAPOLI-1: phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
ONCOLOGY RESEARCH AND TREATMENT（2016）
关键词
metastatic pancreatic cancer,pancreatic cancer,leucovorin,nal-iri,gemcitabine-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要